DEXYCU (Dexamethasone Intraocular Suspension) 9% Retrospective Study 001

NCT04290676 · clinicaltrials.gov ↗

COMPLETED

Status

527

Enrollment

INDUSTRY

Sponsor class

Conditions

Cataract

Interventions

DRUG: DEXYCU (dexamethasone intraocular suspension) 9%.

Sponsor

EyePoint Pharmaceuticals, Inc.